<SEC-DOCUMENT>0001193125-22-252592.txt : 20220928
<SEC-HEADER>0001193125-22-252592.hdr.sgml : 20220928
<ACCEPTANCE-DATETIME>20220928060759
ACCESSION NUMBER:		0001193125-22-252592
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220928
FILED AS OF DATE:		20220928
DATE AS OF CHANGE:		20220928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEGON NV
		CENTRAL INDEX KEY:			0000769218
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10882
		FILM NUMBER:		221272706

	BUSINESS ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
		BUSINESS PHONE:		011-31-70-344-7308

	MAIL ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d379267d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Securities and Exchange Commission
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Issuer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule <FONT STYLE="white-space:nowrap">13a-16</FONT> or 15d/16 of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>September 2022 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Aegon N.V.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Aegonplein 50 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2591 TV
THE HAGUE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon&#146;s press release, dated September&nbsp;27, 2022, is included as appendix and incorporated herein
by reference. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Aegon N.V.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: September&nbsp;28, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">By /s/ J.O. van Klinken</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">J.O. van Klinken</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Executive Vice President and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">General Counsel</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g379267tx3.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; September&nbsp;27, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aegon to repurchase shares to neutralize 2022 interim dividend paid in shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon will repurchase common shares for an amount of EUR 133&nbsp;million to neutralize the dilutive effect of the 2022 interim dividend paid in shares. These
shares will be held as treasury shares and will be used to pay future stock dividends in shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders were given the opportunity to choose
between receiving the 2022 interim dividend of EUR 0.11 per common share in cash or in shares. The stock dividend and the cash dividend are approximately equal in value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">60% of shareholders elected to receive the final dividend in shares. Those who elected stock dividend received one Aegon common share for every 42 common
shares held. The stock fraction is based on Aegon&#146;s average share price as quoted on Euronext Amsterdam, using the high and low of each of the five trading days from September&nbsp;8 up to and including September&nbsp;14, 2022. The average
share price calculated on this basis amounted to EUR 4.61. The dividend was paid on September&nbsp;21, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The repurchase of shares will commence on
October&nbsp;3, 2022, and is expected to be completed on or before December&nbsp;15, 2022. The transaction will amount to EUR 133&nbsp;million. Aegon will engage a third party to execute the transaction on its behalf. The common shares will be
repurchased at a maximum of the average of the daily volume-weighted average prices during the repurchase period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This program is in addition to the
existing EUR 300&nbsp;million share buyback that was announced&nbsp;on March<U></U>&nbsp;23, 2022, of which the third tranche of EUR 100&nbsp;million will commence on October&nbsp;3, 2022, and is expected to be completed on or before
December&nbsp;15, 2022, barring unforeseen circumstances. Weekly updates regarding all the share buyback transactions are available on&nbsp;aegon.com. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Aegon </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon is an integrated, diversified, international financial services group. The company offers investment, protection, and retirement solutions, with a
strategic focus on three core markets (the United States, the United Kingdom, and the Netherlands), three growth markets (Spain&nbsp;&amp; Portugal, Brazil, and China), and one global asset manager. Aegon&#146;s purpose of <I>Helping people live
their best lives</I> runs through all its activities. As a leading global investor and employer, the company seeks to have a positive impact by addressing critical environmental and societal issues, with a focus on climate change and
inclusion&nbsp;&amp; diversity. Aegon is headquartered in The Hague, the Netherlands, and listed on Euronext Amsterdam and the New York Stock Exchange. More information can be found at aegon.com. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Contacts</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Media relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investor relations</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dick Schiethart</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jan Willem Weidema</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">+31(0) 6 2288 9925</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+31(0) 70 344 8028</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">dick.schiethart@aegon.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">janwillem.weidema@aegon.com</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g379267tx4.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; September&nbsp;27, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The statements contained in
this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target,
intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar expressions as they relate to Aegon. These statements may contain information about financial
prospects, economic conditions and trends and involve risks and uncertainties. In addition, any statements that refer to sustainability, environmental and social targets, commitments, goals, efforts and expectations and other events or circumstances
that are partially dependent on future events are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation,
and expressly disclaims any duty, to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing.
Actual results may differ materially and adversely from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Unexpected delays, difficulties, and expenses in executing against our environmental, climate, diversity and
inclusion or other &#147;ESG&#148; targets, goals and commitments, and changes in laws or regulations affecting us, such as changes in data privacy, environmental, safety and health laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in general economic and/or governmental conditions, particularly in the United States, the Netherlands
and the United Kingdom; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Civil unrest, <FONT STYLE="white-space:nowrap">(geo-)</FONT> political tensions, military action or other
instability in a country or geographic region; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the performance of financial markets, including emerging markets, such as with regard to:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The frequency and severity of defaults by issuers in Aegon&#146;s fixed income investment portfolios;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting
decline in the value of equity and debt securities Aegon holds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effects of declining creditworthiness of certain public sector securities and the resulting decline in the
value of government exposure that Aegon holds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the performance of Aegon&#146;s investment portfolio and decline in ratings of Aegon&#146;s
counterparties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lowering of one or more of Aegon&#146;s debt ratings issued by recognized rating organizations and the adverse
impact such action may have on Aegon&#146;s ability to raise capital and on its liquidity and financial condition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lowering of one or more of insurer financial strength ratings of Aegon&#146;s insurance subsidiaries and the
adverse impact such action may have on the written premium, policy retention, profitability and liquidity of its insurance subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effect of the European Union&#146;s Solvency II requirements and other regulations in other jurisdictions
affecting the capital Aegon is required to maintain; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets
funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Catastrophic events, either manmade or by nature, including by way of example acts of God, acts of terrorism,
acts of war and pandemics, could result in material losses and significantly interrupt Aegon&#146;s business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The frequency and severity of insured loss events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the
profitability of Aegon&#146;s insurance products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Aegon&#146;s projected results are highly sensitive to complex mathematical models of financial markets,
mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future
performance will vary from projected results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in customer behavior and public opinion in general related to, among other things, the type of products
Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Customer responsiveness to both new products and distribution channels; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As Aegon&#146;s operations support complex transactions and are highly dependent on the proper functioning of
information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate
controls including with respect to third parties with which we do business may disrupt Aegon&#146;s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items,
including Aegon&#146;s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Aegon&#146;s failure to achieve anticipated levels of earnings or operational efficiencies, as well as other
management initiatives related to cost savings, Cash Capital at Holding, gross financial leverage and free cash flow; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the policies of central banks and/or governments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does
business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for
Aegon&#146;s products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consequences of an actual or potential <FONT STYLE="white-space:nowrap">break-up</FONT> of the European monetary
union in whole or in part, or the exit of the United Kingdom from the European Union and potential consequences if other European Union countries leave the European Union; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in laws and regulations, particularly those affecting Aegon&#146;s operations&#146; ability to hire and
retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which
Aegon operates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and
the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the
designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer <FONT STYLE="white-space:nowrap">(G-SII);</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies,
voluntarily or otherwise, which may affect Aegon&#146;s reported results, shareholders&#146; equity or regulatory capital adequacy levels. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation
(596/2014). Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These
forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in Aegon&#146;s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g379267tx3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g379267tx3.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ .:K[ ^)$H * "@!: #% !0 E "T % "4 % !0 N* #% "4
M+0 4 % "4 % "B@ H * $H 6@ % !0 E "T %  : "@ Z4 % !WH * "@!*
M%H * #O0 4#$H$% "T % !TH 2@!<4 % !TH 2@!30 E T>[_#[6AJWAZ*)L
M>;; 1L!Z=J^<QM)PJ-]SZ; 5E.G;L==7$=X4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\M5]@?$A
M0 4 % !0 M !0 4 % !0 &@ H 2@!: $H 7I0 4 )0 M !0 4  H !0 4 %
M"4 +0 4 )0 4 +0 E "B@ H 2@!: "@!* "@ H 6@ H * "@!* "@ H 6@!*
M %H 2@!: $H 6@ H [7X9ZO]@\1_97?;%=+LQ_M=J\[,*3G3YET/2RZKR5.5
M['MXZ5X!](% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % "$XI7L
M!5O-2LM.B\R]NX;=/61PO\ZJ,92?NHB52,/B98BD2:))8V#(X#*PZ$4K-:,I
M--70^@84 % !0 4 % !0 4 % !0 4 ?+=?8'Q(E "T;AL%-@K!4I@!I@% !0
M E "B@ H * %16=PB*68G  &2:3:BKL:3;LA#D<4Q;"4 +0 4 )0 =* "@!:
M $H 6@ H * "@ % !0 4 % !0 4 &* "@ H 2@ H * "@!: "@ H * "@ H
M2@ H 6@ H 2@ H .E "T '2@ H FM;AK2[BN(SAHV##\*F4>9-%0ERR3/HO0
M-475]$M;U./,3D>AKY:M#V51Q/KJ%3VE-21IUD;!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!#<74-I"TUQ-'#&O5Y&"@?B::3;LD3*2BKMG%:I\5-%L
MF>.S26]D7@%!M0G_ 'C_ # -=U++ZL]]#SZN8TZ>VIQ6J_%#7;]&CMO*LHSW
MC&Y_^^C_ $ KTJ674X:RU/,JYE4GHM#&\/Z/>^+M=^S-<N7*EY)Y<R%0._)Y
MY('XUM6K1PT+I&-"E+%5+7\SU'Q!XCD^&O@C3Y)X/[3:*1+7AO*R-K$'HW90
M*^<J352;FEN?348.G!0?0Y9?CA?,H9?!-X5(R")V((_[]UF:G6+\1+6W\!Q^
M*-5LI;$.S(MH3ND9@Q  R!UQGITH&<9_PN[6/)^W_P#"&3?V9G_7>8VW_OO9
MB@#TOPQXIT_Q5H2:M9.5AR5D63 :-AU!_G]#0!P=]\9Y;G49;3POX;NM86'[
M\JAOS"J"<>YQ]* -SP7\3K3Q5?2Z7=V3Z7JT6<V\K9W8ZX) .1Z$?G0!&OQ3
MM4^(C>$[G3S"/.\E;KSL@L1E05QQD\=?2@#5\?>-AX'TBVOS8_;!-.(=@EV8
M^4G.<'TH$=)8W/VRQM[G;L\Z-9-N<XR,XH L4 % 'RW7V!\2':@#HO <:2^,
M[!)$5T(DRK#(_P!6W8UQXYVHMG;@5>LHOJ/T7Q!?W6MV-K=>3<6T\R121O;H
M0RL0#V]ZBKAZ4*?-#1_,NEB:LII2>C]"&/PO<WUQ?O:R016=K<-$\L\H14Y.
M"2>W%:/$\D8Q=V[&:PSJ2DUHD[$,'AV:X^UR"]LTM+5@C73R$1LQZ!>,G\JJ
M6(M96U?04,-S-MRT742Y\-7L*6<D#P7<%Y)Y4,L#Y5GSC;R 0?J*4,2I7NK6
MW%+#-*/*[W8Z[\.BQ>:*XU?3UN(0=\(=RP8?PYVXSVZT1Q,I6<8.WJ5+#1A=
M2FKKH-C\.R?8;>[NM0LK)+@;HEF=M[+G&<*IP.#UHEB+2<(QNUN*.&O%3E*R
M>QEW,(M[AXA+',%.-\9)5OID"NB$N979S223LC5TSPQ?ZKIS:A"]O%:)*8GE
MFE"*A !R<]N16%7$QI2Y+:_\%G12PTJD>>^G_ 0V#P]++!/<O>VD%I%*81/*
M[!)&']S )/'/3O0\19J*5VPCA[Q<I.R1IZ'H\VE^+]"9Y89H+B57BFA;<CC.
M#C(!R#U!%85JRJ4)*UFC>E1]E6AK=/J8UEI<^JW\\4)C18PTDDDC;4C4'DD_
ME77.I&E%7U.:-)U)R1)=:#)!I[WT%[:WD$;A)3;LQ,9/3(8 X/3-9T\1S2Y9
M)IE3P_+'F3NA]OH"W A UC34EE VQ-(^X$]B0N ?QI3Q#@W[KLAPPZDE[RNQ
MEKX>O+F]O+61HK4V0)N'G?:L>#CD_7IBJE7C&,9;W(AAYR;CV(+W3H[-$:/4
M;2[W'&V OD?4,HJJ524OCCR_B*I2C'X9)FD/"5R+F.SEU'3X;Z3&+9Y6W@GH
MIPN ?;-8O%JUU%V[FZPFMG+7L8EU;2V5U+;3H4FB8HZ^A!YKJC)2BI+J<DXN
M#LR*J(#I0 4 % "4 % "]* $H * %H * "@ H * $H 7M0 4 '2@ H 2@ H
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M24NHFF>+_B?%I-G';>#[>2W2%%C<HWS*%&#]_P!*Q.@9\4Y6U/XG>$]!N_\
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MJ%&3Z <"NB*Y59'-*3D[L93$)0 M !0 4 % !TH #0 E !0 4 % !0 4 +0
M4 % !0 &@!!0 M "4 % !0 4 % !0 M !0 4 )0 4 % !0 O:@!* #I0'0]X
M^'NL#4_#4,;OF:W^1L]<=J^<QM)TZC?0^GP-95*275'6UQ'>% !0 4 % !0
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MRW7V!\2% !0 4 )0 M "=* %H * $H * %H * "@!* "@!: "@ H * "@ H
M2@!: $H * "@!: $H * "@!: "@!* %H * "@ H * $H 6@!* "@!: "@ H
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4NPP/2BP788'I18+L,#THL%V?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g379267tx4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g379267tx4.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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FH TM!^&>G>'M9@U.WUC5[B6#=B.YN%>,Y4KR H]: .VH * /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
